We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.32B
Cap. Flow
-$1.4B
Cap. Flow %
-7.16%
Top 10 Hldgs %
25.07%
Holding
1,468
New
83
Increased
502
Reduced
673
Closed
84

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$112M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$77.7M
3
MSFT icon
Microsoft
MSFT
+$65.3M
4
MRK icon
Merck
MRK
+$61.7M
5
HD icon
Home Depot
HD
+$42.2M

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Financials 10.7%
3 Healthcare 9.86%
4 Consumer Discretionary 9.05%
5 Industrials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
126
Intel
INTC
$462B
$30.3M 0.15%
1,512,410
+343,723
+29% +$7.75M
ICE icon
127
Intercontinental Exchange
ICE
$84.1B
$30M 0.15%
201,453
+1,792
+0.9% +$284K
ETN icon
128
Eaton
ETN
$155B
$29.9M 0.15%
90,077
+3,506
+4% +$1.23M
APD icon
129
Air Products & Chemicals
APD
$65.2B
$29.6M 0.15%
102,071
-10,208
-9% -$3.21M
TEL icon
130
TE Connectivity
TEL
$60.2B
$29.2M 0.15%
203,894
+9,630
+5% +$1.43M
ISRG icon
131
Intuitive Surgical
ISRG
$128B
$28.6M 0.15%
54,735
+1,170
+2% +$609K
UPS icon
132
United Parcel Service
UPS
$96B
$28.5M 0.15%
226,037
-118,572
-34% -$15.6M
IBM icon
133
IBM
IBM
$204B
$27.8M 0.14%
126,609
-43,668
-26% -$9.73M
USB icon
134
US Bancorp
USB
$98.9B
$27.7M 0.14%
578,493
-66,815
-10% -$3.29M
BNY
135
Bank of New York Mellon
BNY
$107B
$27.7M 0.14%
360,058
-38,874
-10% -$3M
BDX icon
136
Becton Dickinson
BDX
$43.8B
$26.8M 0.14%
118,027
-1,784
-1% -$412K
ZTS icon
137
Zoetis
ZTS
$32.2B
$26.4M 0.13%
162,085
+13,798
+9% +$2.47M
REGN icon
138
Regeneron Pharmaceuticals
REGN
$69.9B
$26.4M 0.13%
37,010
+30,915
+507% +$25.9M
PM icon
139
Philip Morris
PM
$305B
$26.3M 0.13%
218,798
-20,661
-9% -$2.61M
HPE icon
140
Hewlett Packard
HPE
$63.8B
$26.3M 0.13%
1,232,940
-164,569
-12% -$3.47M
AXTA icon
141
Axalta
AXTA
$7.22B
$26.3M 0.13%
768,074
+13,535
+2% +$509K
WAL icon
142
Western Alliance Bancorporation
WAL
$9.04B
$25.8M 0.13%
309,343
-2,643
-0.8% -$233K
EW icon
143
Edwards Lifesciences
EW
$47.8B
$25.8M 0.13%
349,050
-32,118
-8% -$2.25M
EXPE icon
144
Expedia Group
EXPE
$33.4B
$25.7M 0.13%
137,699
+3,293
+2% +$567K
NVO
145
Novo Nordisk
NVO
$220B
$25.6M 0.13%
297,592
+2,162
+0.7% +$234K
SYK icon
146
Stryker
SYK
$129B
$24.9M 0.13%
69,030
+880
+1% +$326K
OKE icon
147
Oneok
OKE
$56.4B
$24.8M 0.13%
246,865
-55,080
-18% -$5.63M
BKR icon
148
Baker Hughes
BKR
$60.1B
$24.8M 0.13%
604,191
-49,854
-8% -$2.01M
TGT icon
149
Target
TGT
$63.7B
$24.6M 0.13%
181,897
-7,627
-4% -$1.09M
GILD icon
150
Gilead Sciences
GILD
$162B
$24.3M 0.12%
263,376
-28,672
-10% -$2.58M

Similar funds

Glenmede Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Glenmede Trust held 1,468 positions worth $19.6B, down 6.3% from $20.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Glenmede Trust withdrew a net $1.4B in Q4 2024, closing 84 positions and reducing 673 holdings. Its most notable exit was Primo Water Corporation, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Glenmede Trust opened a new position in Brink's worth $14.5M.

  • Glenmede Trust's largest Q4 2024 buy was Brink's: 156,825 shares worth $14.5M.
  • Glenmede Trust added most to iShares Russell 2500 ETF in Q4 2024, an estimated $99.1M increase.
  • Glenmede Trust's biggest Q4 2024 reduction was Apple, cutting an estimated $112M.
  • Glenmede Trust fully exited Primo Water Corporation in Q4 2024, selling an estimated $19.8M.
  • Glenmede Trust's ten largest holdings make up 25% of its $19.6B portfolio in Q4 2024.
  • Glenmede Trust opened 83 new positions and closed 84 in Q4 2024.
  • Glenmede Trust's portfolio value fell 6.3% quarter-over-quarter to $19.6B.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.